Article Text

Download PDFPDF

What clinical signs best identify severe illness in young infants aged 0–59 days in developing countries? A systematic review
  1. Newton Opiyo1,
  2. Mike English1,2
  1. 1KEMRI/Wellcome Trust Research Programme, Nairobi, Kenya
  2. 2Department of Paediatrics, University of Oxford, Oxford, UK
  1. Correspondence to Newton Opiyo, KEMRI/Wellcome Trust Research Programme, P.O. Box 43640, 00100 GPO, Nairobi, Kenya; nopiyo{at}nairobi.kemri-wellcome.org

Abstract

Despite recent overall improvement in the survival of under-five children worldwide, mortality among young infants remains high, and accounts for an increasing proportion of child deaths in resource-poor settings. In such settings, clinical decisions for appropriate management of severely ill infants have to be made on the basis of presenting clinical signs, and with limited or no laboratory facilities. This review summarises the evidence from observational studies of clinical signs of severe illnesses in young infants aged 0–59 days, with a particular focus on defining a minimum set of best predictors of the need for hospital-level care. Available moderate to high quality evidence suggests that, among sick infants aged 0–59 days brought to a health facility, the following clinical signs—alone or in combination—are likely to be the most valuable in identifying infants at risk of severe illness warranting hospital-level care: history of feeding difficulty, history of convulsions, temperature (axillary) ≥37.5°C or <35.5°C, change in level of activity, fast breathing/respiratory rate ≥60 breaths per minute, severe chest indrawing, grunting and cyanosis.

This paper is freely available online under the BMJ Journals unlocked scheme, see http://adc.bmj.com/info/unlocked.dtl

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Funding Mike English is funded by a Wellcome Trust Senior Fellowship (#076827) and Newton Opiyo is supported by funding from a Wellcome Trust Strategic Award (#084538).

  • Competing interests None.

  • Provenance and peer review Not commissioned; externally peer reviewed.